Taysha completes dosing in Rett syndrome pivotal trial, reports data

June 22, 2026 8:00 AM

Taysha Gene Therapies (Nasdaq: TSHA) announced the completion of dosing in its REVEAL pivotal trial and released longer-term clinical data ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found